Source link : https://newshealth.biz/health-news/fda-oks-guselkumab-for-crohns-disease/
The US Food and Drug Administration (FDA) approved guselkumab (Tremfya, Johnson & Johnson) for the treatment of adults with moderately to severely active Crohn’s disease (CD). The approval marks the fourth indication for guselkumab, which was approved for moderate to severe plaque psoriasis in 2017, active psoriatic arthritis in 2020, and moderately to severely active […]
The post FDA OKs Guselkumab for Crohn’s Disease first appeared on News Health.
Author : News Health
Publish date : 2025-03-25 07:03:00
Copyright for syndicated content belongs to the linked Source.
in Health